Company: PTPI
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001410578-25-000579
Chunk: 4

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 12S
Chunk 4
---
 ​​​​​​Alto Opportunity Master Fund, SPC-Segregated Master Portfolio B(3)  5,416,663  9.39%   —​ —​Iroquois Capital Management L.L.C.(4)  5,939,283  9.99%   182.63​32.16%Intracoastal Capital LLC(5)  2,810,545  4.99%   136.19​ 23.98%Five Narrow Lane LP(6)  2,744,894  4.99%   36.90​6.50%3i, LP(7)  2,744,894  4.99%   107.69​18.96%Brio Capital Master Fund Ltd. (8)​ 2,243,582​ 4.02% 38.46​6.77%V4 Global, LLC(9)​ 1,794,877​ 3.25% 30.77​5.42%StenED, LLC(10)​ 2,542,546​4.54% 35.21​6.20%Named Executive Officers and Directors ​ ​​​​​​Bruce T. Bernstein(11)  392,347 *​ —​ —​Joshua N. Silverman(12)  1,095,238  2.04% —​ —​Wayne R. Walker(13)​ 242,315​*​ —​ —​Fady Boctor(14)​ 575,745​ 1.07%   —​ —​Mitchell Arnold(15)  175,117 *​ —​ —​All directors and executive officers as a group (5 persons)​ 2,480,762​ 4.61%   —​ —​

*represents ownership of less than 1%.